Skip to menu Skip to content Skip to footer

2019

Journal Article

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress

Koloski, Natasha, Jones, Michael, Walker, Marjorie M., Veysey, Martin, Zala, Alkesh, Keely, Simon, Holtmann, Gerald and Talley, Nicholas J. (2019). Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Alimentary Pharmacology and Therapeutics, 49 (5), 546-555. doi: 10.1111/apt.15120

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress

2019

Journal Article

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

Shah, Ayesha, Morrison, Mark, Burger, Daniel, Martin, Neal, Rich, Justin, Jones, Mike, Koloski, Natasha, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald J. (2019). Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 49 (6), 624-635. doi: 10.1111/apt.15133

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

2019

Journal Article

The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences

Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., Shinohara, R. T. and Mullin, G. E. (2019). The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences. BMC Complementary and Alternative Medicine, 19 (1) 21, 21. doi: 10.1186/s12906-018-2409-0

The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences

2019

Journal Article

Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis

Shah, Ayesha, Crawford, Darrel, Burger, Daniel, Martin, Neal, Walker, Marjorie, Talley, Nicholas J., Tallis, Caroline, Jones, Michael, Stuart, Katherine, Keely, Simon, Lewindon, Peter, MacDonald, Graeme A., Morrison, Mark and Holtmann, Gerald J. (2019). Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis. Seminars in Liver Disease, 39 (4), 432-441. doi: 10.1055/s-0039-1688501

Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis

2019

Journal Article

Immune activation in functional gastrointestinal disorders

Burns, Grace, Pryor, Jennifer, Holtmann, Gerald, Walker, Marjorie M., Talley, Nicholas J. and Keely, Simon (2019). Immune activation in functional gastrointestinal disorders. Gastroenterology and Hepatology, 15 (10), 539-548.

Immune activation in functional gastrointestinal disorders

2019

Journal Article

Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches

Holtmann, Gerald, Schrenk, Dietmar, Madisch, Ahmed, Allescher, Hans D., Ulrich-Merzenich, Gudrun, Mearin, Fermin, Larrey, Dominique and Malfertheiner, Peter (2019). Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches. Digestive Diseases, 38 (4), 1-11. doi: 10.1159/000504570

Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches

2019

Book Chapter

Clinical conditions associated with bacterial overgrowth

Shah, Ayesha and Holtmann, Gerald (2019). Clinical conditions associated with bacterial overgrowth. Gastrointestinal diseases and their associated infections. (pp. 67-83) edited by Guy D. Eslick. St. Louis, MO, United States: Elsevier. doi: 10.1016/B978-0-323-54843-4.00006-4

Clinical conditions associated with bacterial overgrowth

2019

Conference Publication

273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study

Bray, Nicola, Koloski, Natasha A., Jones, Michael P., Do, Anh, Talley, Nicholas J., McAllister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Che-yung, Billin, Abi, Bettens, Gemma, Catague, Rachel, Whaley, Amanda, Macdonald, Graeme A. and Holtmann, Gerald J. (2019). 273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study. Digestive Disease Week 2019, San Diego, CA, United States, 18-21 May 2019. PHILADELPHIA: Elsevier BV. doi: 10.1016/s0016-5085(19)36917-3

273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study

2019

Conference Publication

Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms

Bray, Nicola, Koloski, Natasha A., Jones, Michael P., Do, Anh, Talley, Nicholas J., Billin, Abi, Bettens, Gemma, McAllister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Che-Yung, Catague, Rachel, Whaley, Amanda, Macdonald, Graeme A. and Holtmann, Gerald (2019). Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms. Digestive Disease Week, San Diego, CA, United States, 18-21 May, 2019. PHILADELPHIA: Elsevier BV. doi: 10.1016/s0016-5085(19)39623-4

Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms

2019

Conference Publication

Factorial analysis-based assessment of the Mucosa Associated Microbiome

Holtmann, Gerald, Morrison, Mark, Talley, Nicholas, Koloski, Natasha, Shah, Ayesha and Jones, Michael (2019). Factorial analysis-based assessment of the Mucosa Associated Microbiome. Asia Pacific Digestive Week, Kolkata, India, 12–15 December 2019. Hoboken, NJ United States: Wiley.

Factorial analysis-based assessment of the Mucosa Associated Microbiome

2018

Journal Article

Gastroduodenal "Dysbiosis": a new clinical entity

Shah, Ayesha, Morrison, Mark and Holtmann, Gerald J. (2018). Gastroduodenal "Dysbiosis": a new clinical entity. Current Treatment Options in Gastroenterology, 16 (4), 591-604. doi: 10.1007/s11938-018-0207-x

Gastroduodenal "Dysbiosis": a new clinical entity

2018

Conference Publication

Quantitative PCR as a novel approach to determine influence of density of bacterial colonization on health and disease

Shah, Ayesha, Shanahan, Erin, Berendsen, Erwin, Macdonald, Graeme, Rich, Justin, Ghasemi, Pegah, Hansen, Teressa, Koloski, Natasha, Burger, Daniel, Keeley, Simon, Walker, Marjorie, Talley, Nicholas, Morrison, Mark and Holtmann, Gerald (2018). Quantitative PCR as a novel approach to determine influence of density of bacterial colonization on health and disease. Asian Pacific Digestive Week (APDW). Connecting Excellence on Gastroenterology and Hepatology in Asia-Pacific, Seoul, Korea, 15–18 November 2018. Richmond, VIC, Australia: Wiley-Blackwell.

Quantitative PCR as a novel approach to determine influence of density of bacterial colonization on health and disease

2018

Conference Publication

Systematic review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome

Shah, Ayesha, Talley, Nicholas J., Rich, Justin, Ghasemi, Pegah, Jones, Mike, Kendall, Bradley J., Burger, Daniel, Koloski, Natasha, Walker, Marjorie, Morrison, Mark and Holtmann, Gerald (2018). Systematic review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome. Asian Pacific Digestive Week (APDW), Seoul, Korea, 15–18 November 2018. Hoboken, NJ, United States: Wiley-Blackwell.

Systematic review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome

2018

Conference Publication

Systematic review of the use of oral antibiotic therapy in primary sclerosing cholangitis and inflammatory bowel disease

Shah, Ayesha, Burger, Daniel, Stuart, Katherine, Martin, Neal, Walker, Marjorie, Tallis, Caroline, Jones, Mike, Macdonald, Graeme, Talley, Nicholas, Morrison, Mark and Holtmann, Gerald (2018). Systematic review of the use of oral antibiotic therapy in primary sclerosing cholangitis and inflammatory bowel disease. Asian Pacific Digestive Week (APDW). Connecting Excellence on Gastroenterology and Hepatology in Asia-Pacific, Seoul, Korea, 15–18 November 2018. Richmond, VIC, Australia: Wiley-Blackwell.

Systematic review of the use of oral antibiotic therapy in primary sclerosing cholangitis and inflammatory bowel disease

2018

Conference Publication

Zonulin as a Biomarker to Identify the Irritable Bowel Syndrome (IBS), Functional Dyspepsia (FD), and Non-Celiac Wheat Sensitivity (NCWS)

Talley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M., Jones, Michael, Koloski, Natasha A. and Keely, Simon (2018). Zonulin as a Biomarker to Identify the Irritable Bowel Syndrome (IBS), Functional Dyspepsia (FD), and Non-Celiac Wheat Sensitivity (NCWS). Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Philadelphia, PA, United States, 5-10 October 2018. Philadelphia, PA, United States: Wolters Kluwer Health.

Zonulin as a Biomarker to Identify the Irritable Bowel Syndrome (IBS), Functional Dyspepsia (FD), and Non-Celiac Wheat Sensitivity (NCWS)

2018

Conference Publication

Anti-Cytolethal Distending Toxin B Antibody (Anti-CdtB) Differentiates Functional Dyspepsia From Healthy Controls

Talley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M., Jones, Michael, Koloski, Natasha A. and Keely, Simon (2018). Anti-Cytolethal Distending Toxin B Antibody (Anti-CdtB) Differentiates Functional Dyspepsia From Healthy Controls. Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Philadelphia, PA, United States, 5-10 October 2018. Philadelphia, PA, United States: Wolters Kluwer Health.

Anti-Cytolethal Distending Toxin B Antibody (Anti-CdtB) Differentiates Functional Dyspepsia From Healthy Controls

2018

Conference Publication

Quantitative polymerase chain reaction as a novel approach to determine influence of density of bacterial colonization on health and disease

Shah, A., Shanahan, E., Berendsen, E., Macdonald, G., Rich, J., Ghasemi, P., Hansen, T., Koloski, N., Burger, D., Keely, S., Walker, M., Talley, N. J., Morrison, M. and Holtmann, G. (2018). Quantitative polymerase chain reaction as a novel approach to determine influence of density of bacterial colonization on health and disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “Gut Matters”, Brisbane, QLD Australia, 8-10 September 2018. Richmond, VIC Australia: John Wiley & Sons.

Quantitative polymerase chain reaction as a novel approach to determine influence of density of bacterial colonization on health and disease

2018

Journal Article

A novel treatment for patients with constipation: dawn of a new age for translational microbiome research?

Shah, Ayesha, Morrison, Mark and Holtmann, Gerald (2018). A novel treatment for patients with constipation: dawn of a new age for translational microbiome research?. Indian Journal of Gastroenterology, 37 (5), 388-391. doi: 10.1007/s12664-018-0912-3

A novel treatment for patients with constipation: dawn of a new age for translational microbiome research?

2018

Conference Publication

Perturbation of the gut-brain axis as the mechanism of action for weight reduction in patients treated with a duodenal-jejunal bypass sleeve

Mcmaster, J. J., Rich, G. G., Shanahan, E. R., Do, A. T., Fletcher, L. M., Kutyla, M. J., Tallis, C., Macdonald, G. A., Chachay, V. S., Morrison, M. and Holtmann, G. J. (2018). Perturbation of the gut-brain axis as the mechanism of action for weight reduction in patients treated with a duodenal-jejunal bypass sleeve. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “Gut Matters”, Brisbane, QLD Australia, 8-10 September 2018. Richmond, VIC Australia: John Wiley & Sons.

Perturbation of the gut-brain axis as the mechanism of action for weight reduction in patients treated with a duodenal-jejunal bypass sleeve

2018

Journal Article

Influence of cigarette smoking on the human duodenal mucosa-associated microbiota

Shanahan, Erin R., Shah, Ayesha, Koloski, Natasha, Walker, Marjorie M., Talley, Nicholas J., Morrison, Mark and Holtmann, Gerald J. (2018). Influence of cigarette smoking on the human duodenal mucosa-associated microbiota. Microbiome, 6 (1) 150, 150. doi: 10.1186/s40168-018-0531-3

Influence of cigarette smoking on the human duodenal mucosa-associated microbiota